Transdermal delivery of a melanotropic peptide hormone analogue
- 1 January 1988
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 43 (14), 1111-1117
- https://doi.org/10.1016/0024-3205(88)90469-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Testing of controlled-release transdermal dosage forms. Product development and clinical trialsArchives of Dermatology, 1987
- Stimulation of Follicular Melanogenesis in the Mouse by Topical and Injected MelanotropinsJournal of Investigative Dermatology, 1987
- VII. Topical application of a melanotropic peptide induces systemic follicular melanogenesisLife Sciences, 1987
- [NLE4, D-PHE7]-$aL-MSH: A Superpotent Melanotropin That “Irreversibly” Activates Melanoma TyrosinaseEndocrine Research, 1985
- Stimulation of S91 melanoma tyrosinase activity by superpotent α-melanotropinsMolecular and Cellular Endocrinology, 1985
- [Nle4, D-Phe7]-α-MSH: A superpotent melanotropin with prolonged action on vertebrate chromatophoresComparative Biochemistry and Physiology Part A: Physiology, 1985
- Relative stability of α-melanotropin and related analogues to rat brain homogenatesPeptides, 1984
- αMelanocyte Stimulating Hormone: Chemical Nature and Mechanism of ActionAmerican Zoologist, 1983
- Calcium-Dependent Prolonged Effects on Melanophores of [4-Norleucine, 7-D-Phenylalanine]-α-MelanotropinScience, 1981
- Effect of Diffusional Lag time on Multicompartmental Pharmacokinetics for Transepidermal InfusionJournal of Pharmaceutical Sciences, 1979